PTJ
STJ

Paul Tudor Jones’s St Jude Medical STJ Stock Holding History

Paul Tudor Jones’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-400,000
Closed -$31.9M – 1769
2016
Q3 		$31.9M Buy
+400,000
New +$32.3M 0.75% 17

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Paul Tudor Jones's STJ Position: Q1 2017 in Review

Paul Tudor Jones sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 507,358 shares — an estimated $40.7M sold.

Paul Tudor Jones first reported a position in STJ in Q3 2013 and held it in 13 quarters. The position peaked at $40.7M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Paul Tudor Jones reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Paul Tudor Jones sold 507,358 St Jude Medical shares in Q1 2017, an estimated $40.7M.
  • Paul Tudor Jones first reported a position in St Jude Medical in Q3 2013 and held it in 13 quarters.
  • Paul Tudor Jones's St Jude Medical position peaked at $40.7M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Tudor Investment Corp's 13F filing for Q1 2017, filed 15 May 2017.